Trecondi Europska Unija - nizozemski - EMA (European Medicines Agency)

trecondi

medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoietische stamceltransplantatie - antineoplastische middelen - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.

Strepsils + Lidocaine 20 ml oromucos. spray opl. spuitbus Belgija - nizozemski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

strepsils + lidocaine 20 ml oromucos. spray opl. spuitbus

reckitt benckiser (healthcare) sa-nv - dichloorbenzylalcohol 4,46 mg/ml; lidocaïne 6 mg/ml; amylmetacresol 2,23 mg/ml - spray voor oromucosaal gebruik, oplossing - 20 ml - dichloorbenzylalcohol 4.46 mg/ml; lidocaïne 6 mg; amylmetacresol 2.23 mg/ml - dichlorobenzyl alcohol

Strepsils + Lidocaine 0.6 mg - 1.2 mg - 2 mg zuigtabl. Belgija - nizozemski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

strepsils + lidocaine 0.6 mg - 1.2 mg - 2 mg zuigtabl.

reckitt benckiser (healthcare) sa-nv - dichloorbenzylalcohol 1,2 mg; amylmetacresol 0,6 mg; lidocaïnehydrochloride 2 mg - zuigtablet - 0.6 mg - 1.2 mg - 2 mg - dichloorbenzylalcohol 1.2 mg; lidocaïnehydrochloride 2 mg; amylmetacresol 0.6 mg - dichlorobenzyl alcohol

Vincrisin 1 mg/ml inj. opl. i.v. flac. Belgija - nizozemski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vincrisin 1 mg/ml inj. opl. i.v. flac.

teva pharma belgium sa-nv - vincristinesulfaat 1 mg/ml - oplossing voor injectie - 1 mg/ml - vincristinesulfaat 1 mg/ml - vincristine

Vincrisin 1 mg/ml inj. opl. i.v. flac. Belgija - nizozemski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vincrisin 1 mg/ml inj. opl. i.v. flac.

teva pharma belgium sa-nv - vincristinesulfaat 1 mg/ml - oplossing voor injectie - 1 mg/ml - vincristinesulfaat 1 mg/ml - vincristine

Xylonor Spray 15 g - 0,15 g oromucos. spray opl. spuitbus Belgija - nizozemski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xylonor spray 15 g - 0,15 g oromucos. spray opl. spuitbus

septodont sa-nv - cetrimide 0,15 g; lidocaïne 15 mg - spray voor oromucosaal gebruik, oplossing - 15 g - 0,15 g - cetrimide 1.5 mg/g; cryofluraan; difluorodichloromethaan; lidocaïne 150 mg/g - lidocaine, combinations

Kinespir 10 mg/g gel Belgija - nizozemski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kinespir 10 mg/g gel

teva b.v. - diclofenacdiëthylammonium 11,6 mg/g - eq. diclofenacnatrium 10 mg/g - gel - 10 mg/g - diclofenacdiëthylammonium 11.6 mg/g - diclofenac

Kinespir Forte 20 mg/g gel Belgija - nizozemski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kinespir forte 20 mg/g gel

teva b.v. - diclofenacdiëthylammonium 23,2 mg/g - eq. diclofenacnatrium 20 mg/g - gel - 20 mg/g - diclofenacdiëthylammonium 23.2 mg/g - diclofenac

Nordimet Europska Unija - nizozemski - EMA (European Medicines Agency)

nordimet

nordic group b.v. - methotrexaat - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastische middelen - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Besremi Europska Unija - nizozemski - EMA (European Medicines Agency)

besremi

aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - polycythaemia vera - immunostimulants, - besremi is geïndiceerd als monotherapie bij volwassenen voor de behandeling van polycythaemia vera zonder symptomatische splenomegalie.